These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Sumatriptan for the treatment of undifferentiated primary headaches in the ED. Miner JR; Smith SW; Moore J; Biros M Am J Emerg Med; 2007 Jan; 25(1):60-4. PubMed ID: 17157685 [TBL] [Abstract][Full Text] [Related]
23. Is cluster headache due to indolent inflammation in the cavernous sinus? Mathew NT Cephalalgia; 1998 May; 18(4):172. PubMed ID: 9642490 [No Abstract] [Full Text] [Related]
24. [The role of agonists of serotonin receptor 5HT1B/D in pathogenesis and treatment of migraine attacks]. Stepień A Pol Merkur Lekarski; 1999 Jun; 6(36):341-3. PubMed ID: 10481551 [TBL] [Abstract][Full Text] [Related]
25. Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy. De Vries P; Villalón CM; Saxena PR Eur J Pharmacol; 1999 Jun; 375(1-3):61-74. PubMed ID: 10443565 [TBL] [Abstract][Full Text] [Related]
26. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat. Hoskin KL; Goadsby PJ Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827 [TBL] [Abstract][Full Text] [Related]
27. The discovery and development of the triptans, a major therapeutic breakthrough. Humphrey PP Headache; 2008 May; 48(5):685-7. PubMed ID: 18471110 [TBL] [Abstract][Full Text] [Related]
28. Neurogenic inflammation in the pathophysiology and treatment of migraine. Moskowitz MA Neurology; 1993 Jun; 43(6 Suppl 3):S16-20. PubMed ID: 8389008 [TBL] [Abstract][Full Text] [Related]
29. Function of the peripheral serotoninergic pathways in migraine: a proposal for an experimental model. Martelletti P; Stirparo G; Rinaldi C; Fusco BM Cephalalgia; 1994 Feb; 14(1):11-5; discussion 4. PubMed ID: 7515328 [TBL] [Abstract][Full Text] [Related]
30. [Present problems of migraine and similar headaches]. Prusiński A Neurol Neurochir Pol; 1994; 28(1 Suppl 1):5-22. PubMed ID: 7915020 [TBL] [Abstract][Full Text] [Related]
31. Treatment of primary headache in the emergency department. Mellick LB; Mellick GA Headache; 2004 Sep; 44(8):840-1. PubMed ID: 15330841 [No Abstract] [Full Text] [Related]
32. Brain structure and function related to headache: Brainstem structure and function in headache. Vila-Pueyo M; Hoffmann J; Romero-Reyes M; Akerman S Cephalalgia; 2019 Nov; 39(13):1635-1660. PubMed ID: 29969040 [TBL] [Abstract][Full Text] [Related]
33. Daily sumatriptan for detoxification from rebound. Drucker P; Tepper S Headache; 1998 Oct; 38(9):687-90. PubMed ID: 15613182 [TBL] [Abstract][Full Text] [Related]
34. Pathophysiology of headache--past and present. Moskowitz MA Headache; 2007 Apr; 47 Suppl 1():S58-63. PubMed ID: 17425711 [No Abstract] [Full Text] [Related]
35. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288. Knight YE; Edvinsson L; Goadsby PJ Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470 [TBL] [Abstract][Full Text] [Related]
36. Mechanisms and functions of serotonin neuronal systems: opportunities for neuropeptide interactions. Fuller RW Ann N Y Acad Sci; 1996 Mar; 780():176-84. PubMed ID: 8602731 [No Abstract] [Full Text] [Related]
37. New migraine and pain research. Hargreaves R Headache; 2007 Apr; 47 Suppl 1():S26-43. PubMed ID: 17425708 [TBL] [Abstract][Full Text] [Related]
38. Sumatriptan--a new treatment of migraine. Neighbor ML West J Med; 1993 Nov; 159(5):597-8. PubMed ID: 8279161 [No Abstract] [Full Text] [Related]
39. Present and future of 5-HT receptor agonists as antimigraine drugs. Pauwels PJ; John GW Clin Neuropharmacol; 1999; 22(3):123-36. PubMed ID: 10367177 [TBL] [Abstract][Full Text] [Related]
40. Open label study of intranasal sumatriptan (Imigran) for footballer's headache. McCrory P; Heywood J; Ugoni A Br J Sports Med; 2005 Aug; 39(8):552-4. PubMed ID: 16046342 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]